Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical

Futaba Inoue1, Kenbun Sone1, Yusuke Toyohara1

  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan.

Insights

Epigenetic changes like DNA methylation are key in endometrial cancer development. This review covers their role, diagnostic tools, and emerging epigenetic drugs in trials.

Area of Science:

  • Gynecological Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Endometrial cancer is a common gynecological malignancy with poor prognosis in advanced stages.
  • Limited treatment options exist for recurrent endometrial cancer.
  • Epigenetic dysregulation, including DNA methylation and histone modification, is implicated in various cancers.

Purpose of the Study:

  • To review the role of DNA methylation and histone modification in endometrial cancer.
  • To discuss diagnostic tools for these epigenetic modifications.
  • To summarize epigenetic inhibitors in preclinical and clinical development for endometrial cancer.

Main Methods:

  • Literature review focusing on DNA methylation and histone modification in endometrial cancer.
  • Analysis of current diagnostic techniques for epigenetic alterations.
  • Survey of ongoing preclinical and clinical trials for epigenetic drugs.

Main Results:

  • Epigenetic dysregulation, particularly DNA methylation and histone modification, significantly contributes to endometrial cancer initiation and progression.
  • Various diagnostic tools are available to detect these epigenetic changes.
  • Several inhibitors targeting epigenetic regulators are under investigation in preclinical and clinical settings.

Conclusions:

  • Epigenetic modifications play a crucial role in endometrial cancer.
  • Diagnostic advancements aid in understanding these changes.
  • Targeting epigenetic regulators offers promising therapeutic strategies for endometrial cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.0K